Lead-203 as a label for radioimaging
Patent
·
OSTI ID:1176609
A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-76CH00016
- Assignee:
- The United States of America as represented by the United States Department of Energy (Washington, DC)
- Patent Number(s):
- H000735
- Application Number:
- 07/175424
- OSTI ID:
- 1176609
- Resource Relation:
- Patent File Date: 1988 Mar 30
- Country of Publication:
- United States
- Language:
- English
Similar Records
Lead-203 as a label for radioimaging
Development of a new radiolabel (lead-203) and new chelating agents for labeling monoclonal anntibodies for imaging
Labeling of monoclonal antibodies with radionuclides
Patent
·
Mon Jan 01 00:00:00 EST 1990
·
OSTI ID:1176609
Development of a new radiolabel (lead-203) and new chelating agents for labeling monoclonal anntibodies for imaging
Conference
·
Fri Jan 01 00:00:00 EST 1988
·
OSTI ID:1176609
+2 more
Labeling of monoclonal antibodies with radionuclides
Journal Article
·
Sat Jul 01 00:00:00 EDT 1989
· Seminars in Nuclear Medicine; (USA)
·
OSTI ID:1176609